Literature DB >> 12893771

Lack of alpha 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice.

Hiroyuki Matsuno1, Akira Ishisaki, Keiichi Nakajima, Kiyotaka Okada, Shigeru Ueshima, Osamu Matsuo, Osamu Kozawa.   

Abstract

We here report that the arterial blood flow after endothelial injury in mice deficient in alpha 2-antiplasmin (alpha 2-AP-/- mice) was well maintained compared with that of wild-type mice. Moreover, the development of neointima 4 weeks after injury in alpha 2-AP-/- mice was significantly decreased. Histologic observations showed a prompt recovery of endothelial cells with a much higher proliferating index in repaired endothelium in alpha 2-AP-/- mice. The amount of secreted vascular endothelial growth factor (VEGF) by explanted vascular smooth muscle cells (SMCs) from alpha 2-AP-/- mice was significantly increased. In separate experiments using a human endothelial cell (EC) line, we could demonstrate that plasminogen binds to ECs and that this binding can be prevented by alpha 2-AP. Finally, an injection of either an anti-VEGF receptor-1 antibody or alpha 2-AP reduced the prompt endothelial healing. alpha 2-AP is the main inactivator of plasmin, which cleaves extracellular matrix-bound VEGF to release a diffusible proteolytic fragment. Lack of alpha 2-AP, therefore, could lead to a local over-release of VEGF by the continuously active plasmin in the injured area, which could result in a prompt re-endothelialization after vascular injury. Our results provide new insight into the role of alpha 2-AP and VEGF in the pathogenesis of re-endothelialization following vascular injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893771     DOI: 10.1182/blood-2003-03-0700

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function.

Authors:  Yosuke Kanno; Akira Ishisaki; Eri Kawashita; Naoyuki Chosa; Keiichi Nakajima; Tatsuji Nishihara; Kuniaki Toyoshima; Kiyotaka Okada; Shigeru Ueshima; Kenji Matsushita; Osamu Matsuo; Hiroyuki Matsuno
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

2.  alpha2-antiplasmin is associated with the progression of fibrosis.

Authors:  Yosuke Kanno; Eri Kawashita; Misato Minamida; Aki Kaneiwa; Kiyotaka Okada; Shigeru Ueshima; Osamu Matsuo; Hiroyuki Matsuno
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

3.  Relation of α2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis.

Authors:  Berthold Hoppe; Christian Schwedler; Hildrun Haibel; Maryna Verba; Fabian Proft; Mikhail Protopopov; Hans-Gert Heuft; Valeria Rios Rodriguez; Anke Edelmann; Martin Rudwaleit; Joachim Sieper; Denis Poddubnyy
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

4.  Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.

Authors:  Satish Singh; Sofiyan Saleem; Guy L Reed
Journal:  Front Cardiovasc Med       Date:  2020-12-23

5.  Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastography.

Authors:  Mengyun Lu; Kevin P Blaine; Ann Cullinane; Courtney Hall; Alina Dulau-Florea; Junfeng Sun; Herman F Chenwi; Grace M Graninger; Bonnie Harper; Keshia Thompson; Janell Krack; Christopher F Barnett; Samuel B Brusca; Jason M Elinoff; Michael A Solomon
Journal:  Pulm Circ       Date:  2021-06-24       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.